 |
|
|
| |
Dolutegravir (DTG) resistance among ART-experienced
viremic patients in Kenya receiving DTG-based ART
|
| |
| |
CROI 2024 March 3-6 Denver
Leonard Kingwara1, Vera Morangi1, Rukia Madada1, Peter Lokamar1, John Kiruu1, James Wagude2, Barbara Mambo3, Caroline Mwangi3, Rose Wafula3, Kerri Penrose4, Urvi Parikh4, Bhavna Chohan5
1Genomics and Molecular Surveillance Laboratory, KNPHI, Nairobi, Kenya; 2Siaya County Government, Kisumu, Kenya; 3National AIDS and STI Control Program, Nairobi, Kenya; 4University of Pittsburgh, Pittsburgh, PA, USA, 5University of Washington, Seattle, WA, USA
|
| |
|
|
|
|
|
